doi: 10.1001/jama.2011.1102.
European drug agency under fire: critics charge that trial data are too inaccessible
- PMID: 21828315
- DOI: 10.1001/jama.2011.1102
Item in Clipboard
European drug agency under fire: critics charge that trial data are too inaccessible
JAMA.
.
No abstract available
Similar articles
-
Restoring confidence in the pharmaceutical industry.JAMA. 2013 Feb 13;309(6):607-9. doi: 10.1001/jama.2013.58. JAMA. 2013. PMID: 23403686 No abstract available.
-
Critics say FDA's off-label guidance allows marketing disguised as science.JAMA. 2008 Apr 16;299(15):1759-61. doi: 10.1001/jama.299.15.1759. JAMA. 2008. PMID: 18413865 No abstract available.
-
[Beyond "data sharing"].Med Clin (Barc). 2015 Jun 22;144(12):548-9. doi: 10.1016/j.medcli.2015.02.005. Epub 2015 Apr 2. Med Clin (Barc). 2015. PMID: 25843632 Spanish. No abstract available.
-
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.
-
Drug development: how academia, industry and authorities interact.Nat Rev Nephrol. 2014 Oct;10(10):602-10. doi: 10.1038/nrneph.2014.133. Epub 2014 Aug 5. Nat Rev Nephrol. 2014. PMID: 25092151 Review.
Cited by
-
Views of Ethical Best Practices in Sharing Individual-Level Data From Medical and Public Health Research: A Systematic Scoping Review.J Empir Res Hum Res Ethics. 2015 Jul;10(3):225-38. doi: 10.1177/1556264615594767. J Empir Res Hum Res Ethics. 2015. PMID: 26297745 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
